Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Omalizumab”

215 trials

Showing 20 of 215 results

Large-scale testing (Phase 3)Study completedNCT00079937
What this trial is testing

Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 628
Not applicableLooking for participantsNCT07425639
What this trial is testing

ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar

Who this might be right for
Chronic Spontaneous Urticaria (CSU)Allergic Asthma
Celltrion HealthCare France 225
Early research (Phase 1)Study completedNCT05053334
What this trial is testing

Biosimilar Study Comparing PK, PD, Safety and Immunogencity of BP11 With US Licensed Xolair and EU Approved Xolair

Who this might be right for
Healthy Volunteers
Syneos Health 165
Early research (Phase 1)Study completedNCT01716312
What this trial is testing

Omalizumab for Lupus

Who this might be right for
Systemic Lupus ErthematosusSjogren's Syndrome
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 17
Not applicableStudy completedNCT05626257
What this trial is testing

Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps

Who this might be right for
Chronic Rhinosinusitis With Nasal Polyps
Novartis Pharmaceuticals 135
Large-scale testing (Phase 3)UnknownNCT01113437
What this trial is testing

Omalizumab in Non-atopic Asthma

Who this might be right for
Bronchial Asthma
King's College London 40
Testing effectiveness (Phase 2)Study completedNCT01290913
What this trial is testing

Xolair Enhances Oral Desensitization in Peanut Allergic Patients

Who this might be right for
Peanut Allergy
Lynda Schneider 13
Testing effectiveness (Phase 2)Study completedNCT02388997
What this trial is testing

Treatment With Omalizumab to Improve the Asthmatic Response to Rhinovirus Experimental Infection With Rhinovirus

Who this might be right for
Asthma
University of Virginia 31
Post-approval studies (Phase 4)Ended earlyNCT04195958
What this trial is testing

Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

Who this might be right for
Moderate-to-severe Allergic Asthma
Genentech, Inc. 3
Early research (Phase 1)Study completedNCT02266355
What this trial is testing

Role of Omalizumab in Reducing the Incidence of Oxaliplatin-induced Hypersensitivity Reaction

Who this might be right for
Colon Cancer
Yale University 9
Post-approval studies (Phase 4)Study completedNCT00283504
What this trial is testing

A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy

Who this might be right for
ALLERGIC ASTHMA
Children's Hospital of The King's Daughters 13
Testing effectiveness (Phase 2)UnknownNCT04720612
What this trial is testing

COVID-19 Immunologic Antiviral Therapy With Omalizumab

Who this might be right for
Covid19
McGill University Health Centre/Research Institute of the McGill University Health Centre 40
Early research (Phase 1)Study completedNCT00260702
What this trial is testing

Omalizumab to Treat Hyper-IgE (Job's) Syndrome

Who this might be right for
Hyper-IgE SyndromeJob's Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 1
Large-scale testing (Phase 3)Study completedNCT00401596
What this trial is testing

Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO)

Who this might be right for
Asthma
Genentech, Inc. 1,899
Post-approval studies (Phase 4)Study completedNCT00454051
What this trial is testing

Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 31
Post-approval studies (Phase 4)Active Not RecruitingNCT06437171
What this trial is testing

FeNO as a Marker of Allergic Reactions to OFC and Response of OMA Treatment in Multiple FA

Who this might be right for
Food Allergy
AAADRS Clinical Research Center 20
Post-approval studies (Phase 4)Study completedNCT02966314
What this trial is testing

Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy

Who this might be right for
Idiopathic Angioedema
University of Wisconsin, Madison 12
Large-scale testing (Phase 3)Study completedNCT00109200
What this trial is testing

A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma

Who this might be right for
Asthma
Genentech, Inc.
Testing effectiveness (Phase 2)Study completedNCT06103656
What this trial is testing

E-B-FAHF-2, Multi OIT and Xolair for Food Allergy

Who this might be right for
Food Allergy
New York Medical College 33
Post-approval studies (Phase 4)Ended earlyNCT02658877
What this trial is testing

Sputum-derived Cellular Targets After Xolair (Omalizumab)

Who this might be right for
Asthma
NYU Langone Health 3
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation